Quality Improvement for Quality Improvement Studies

Deborah Grady¹, Rita F Redberg^{1

2}, Patrick G O'Malley³

Affiliations

Editorial

Deborah Grady et al. JAMA Intern Med. 2018.

. 2018 Feb 1;178(2):187.

doi: 10.1001/jamainternmed.2017.6875.

Deborah Grady¹, Rita F Redberg^{1

2}, Patrick G O'Malley³

No abstract available

Comment in

Rigor in Quality Improvement Studies and the Role of Time-Series Methodologies.
Wong BM, Shojania KG. Wong BM, et al. JAMA Intern Med. 2018 May 1;178(5):724-725. doi: 10.1001/jamainternmed.2018.0863. JAMA Intern Med. 2018. PMID: 29801128 No abstract available.
Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease.
Zaheen A, Anand A, Stanbrook MB. Zaheen A, et al. JAMA Intern Med. 2018 May 1;178(5):730-731. doi: 10.1001/jamainternmed.2018.1442. JAMA Intern Med. 2018. PMID: 29801135 No abstract available.
Rigor in Quality Improvement Studies and the Role of Time-Series Methodologies-Reply.
O'Malley PG, Redberg RF, Grady D. O'Malley PG, et al. JAMA Intern Med. 2018 May 1;178(5):725-726. doi: 10.1001/jamainternmed.2018.0872. JAMA Intern Med. 2018. PMID: 29801136 No abstract available.
Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease-Reply.
Wang MT, Wang YH, Tsai CL. Wang MT, et al. JAMA Intern Med. 2018 May 1;178(5):731. doi: 10.1001/jamainternmed.2018.1450. JAMA Intern Med. 2018. PMID: 29801141 No abstract available.